|
⚲
|
| Keyboard |
| Suvretta Capital Management LLC | |
|---|---|
| Firm | Suvretta Capital Management LLC |
| Address | 540 Madison Avenue 7th Floor New York, NY 10022 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Suvretta Capital Management LLC | |||||
| Averill Opportunities Offshore Fund I LP | 021-386148 | Executive Officer | 14.9 M | 0.1 M | |
| Averill Master Fund Ltd | 021-363912 | Executive Officer | 594.4 M | 4,308.6 M | |
| Suvretta Long Master Fund Ltd | 021-316181 | Executive Officer | 42.0 M | 2.3 M | |
| Suvretta Master Fund Ltd | 021-185190 | Executive Officer | 619.2 M | 2,702.2 M | |
| Averill Opportunities Offshore Fund I LP | 021-386150 | Executive Officer | 0.1 M | ||
| Averill Fund Ltd | 021-363913 | Executive Officer | 267.0 M | ||
| Suvretta Long Partners LP | 021-278304 | Executive Officer | 50.3 M | ||
| Suvretta Partners LP | 021-184125 | Executive Officer | 1,315.6 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-06 | Buy | 19,338 | $36.55 | 706,804 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-06 | Buy | 11,183 | $35.97 | 402,253 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 16,563 | $39.80 | 659,207 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 17,835 | $38.67 | 689,679 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 38,771 | $37.63 | 1,458,953 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 19,199 | $36.93 | 709,019 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-05 | Buy | 3,832 | $36.07 | 138,220 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 25,908 | $38.09 | 986,836 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 53,344 | $37.11 | 1,979,596 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 3,178 | $38.90 | 123,624 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 10,676 | $34.74 | 370,884 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 10,004 | $34.25 | 342,637 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 14,659 | $36.27 | 531,682 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 4,453 | $38.09 | 169,615 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 9,168 | $37.11 | 340,224 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 2,519 | $36.27 | 91,364 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 1,835 | $34.74 | 63,748 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 1,720 | $34.25 | 58,910 |
|
Veradermics Inc MANE
Common stock, par value $0.00001 per share
|
2026-02-04 | Buy | 18,489 | $38.90 | 719,222 |
|
Benitec Biopharma Inc BNTC
Common stock, par value $0.0001 per share
|
2025-12-29 | Buy | 11,587 | $13.44 | 155,729 |
| showing 20 of 59 most recent transactions | |||||